Lipid-lowering therapy in individuals with CKD: Lessons learned from SHARP

American Journal of Kidney Diseases

Volumn 59, Issue 2, 2012, Pages 170-173

  Upadhyay, Ashish ^a   Weiner, Daniel E ^a  

^a TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; EZETIMIBE; FLUINDOSTATIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; ROSUVASTATIN; SIMVASTATIN;

CHRONIC KIDNEY DISEASE; CORONARY ARTERY ATHEROSCLEROSIS; DISEASE COURSE; DRUG DOSE INCREASE; DRUG SAFETY; GLOMERULUS FILTRATION RATE; HEMODIALYSIS; HUMAN; PERITONEAL DIALYSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW;

EID: 84855851885     PISSN: 02726386     EISSN: 15236838     Source Type: Journal    
DOI: 10.1053/j.ajkd.2011.09.008     Document Type: Editorial

References (16)

1. R.N. Foley, P.S. Parfrey, M.J. Sarnak Clinical epidemiology of cardiovascular disease in chronic renal disease Am J Kidney Dis 32 5 1998 S112 S119 (suppl 3)
2. Cholesterol Treatment Trialists' (CTT) Collaboration C. Baigent, L. Blackwell, J. Emberson et al. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials Lancet 376 9753 2010 1670 1681
3. P.M. Ridker, E. Danielson, F.A. Fonseca JUPITER Study Group Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein N Engl J Med 359 21 2008 2195 2207
4. J. Shepherd, S.M. Cobbe, I. Ford et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia West of Scotland Coronary Prevention Study Group N Engl J Med 333 20 1995 1301 1307
5. B.L. Kasiske Hyperlipidemia in patients with chronic renal disease Am J Kidney Dis 32 5 1998 S142 S156 (suppl 3)
6. D.E. Weiner, M.J. Sarnak Managing dyslipidemia in chronic kidney disease J Gen Intern Med 19 10 2004 1045 1052 (Pubitemid 39431142)
7. M.J. Koren, M.H. Davidson, D.J. Wilson ALLIANCE Investigators Focused atorvastatin therapy in managed-care patients with coronary heart disease and CKD Am J Kidney Dis 53 5 2009 741 750
8. P.M. Ridker, J. MacFadyen, M. Cressman, R.J. Glynn Efficacy of rosuvastatin among men and women with moderate chronic kidney disease and elevated high-sensitivity C-reactive protein: a secondary analysis from the JUPITER (Justification for the Use of Statins in Prevention-an Intervention Trial Evaluating Rosuvastatin) trial J Am Coll Cardiol 55 12 2010 1266 1273
9. J. Shepherd, J.P. Kastelein, V.A. Bittner Treating to New Targets Steering Committee and Investigators Intensive lipid lowering with atorvastatin in patients with coronary artery disease, diabetes, and chronic kidney disease Mayo Clin Proc 83 8 2008 870 879
10. M. Tonelli, A. Keech, J. Shepherd et al. Effect of pravastatin in people with diabetes and chronic kidney disease J Am Soc Nephrol 16 12 2005 3748 3754 (Pubitemid 46211298)
11. C. Wanner, V. Krane, W. Mrz German Diabetes and Dialysis Study Investigators Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis N Engl J Med 353 3 2005 238 248 (Pubitemid 41058323)
12. B.C. Fellstrm, A.G. Jardine, R.E. Schmieder AURORA Study Group Rosuvastatin and cardiovascular events in patients undergoing hemodialysis N Engl J Med 360 14 2009 1395 1407
13. H. Holdaas, B. Fellstrm, A.G. Jardine Assessment of LEscol in Renal Transplantation (ALERT) Study Investigators Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trial Lancet 361 9374 2003 2024 2031 (Pubitemid 36695044)
14. C. Baigent, M.J. Landray, C. Reith SHARP Investigators The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial Lancet 377 9784 2011 2181 2192
15. A.S. Goldfarb-Rumyantzev, A.N. Habib, B.C. Baird, L.L. Barenbaum, A.K. Cheung The association of lipid-modifying medications with mortality in patients on long-term peritoneal dialysis Am J Kidney Dis 50 5 2007 791 802 (Pubitemid 47588556)
16. J. Huskey, J. Lindenfeld, T. Cook et al. Effect of simvastatin on kidney function loss in patients with coronary heart disease: findings from the Scandinavian Simvastatin Survival Study (4S) Atherosclerosis 205 1 2009 202 206